Connections Formycon AG

FYB

DE000A1EWVY8

Biotechnology & Medical Research

Market Closed - Xetra Other stock markets 16:35:43 06/02/2026 GMT			5-day change	1st Jan Change
23.00 ^EUR	+0.88%		0.00%	-10.16%

12-23	Formycon Obtains US FDA Approval for Interchangeable Lucentis Biosimilar	MT
12-23	Formycon AG - FDA approves biologics license application (BLA) for additional ranibizumab biosimilar under trade name Nufymco	RE

8

Listed companies

0

Private companies

25

Insiders

Relation chart of related listed companies: Formycon AG

Active Relations

Past Relations

Related listed companies: Formycon AG

FARON PHARMACEUTICALS OY

ONESOURCE SPECIALTY PHARMA LIMITED

Colin Michael Bond

AGOMAB THERAPEUTICS NV

Colin Michael Bond

Active Relations

Past Relations

Connection statistics

Active

Inactive

Listed companies

Private companies

Activities of related companies

Pharmaceuticals: Major	3
Hospital/Nursing Management	1
Medical Distributors	1
Biotechnology	1

Countries of related companies

Belgium	2
India	2
Germany	1
France	1
Finland	1
United Kingdom	1

Formycon AG is a Germany based Company. The Company is engaged in providing biosimilar drugs and formulations. The Company focuses on treatments in ophthalmology, immunology and other chronic diseases, covering all steps of biosimilar development process, from early-stage analysis of the originator drug to the preclinical and clinical testing phases, as well as the preparation of dossiers for marketing approval.

Employees

250

Sector

Biotechnology & Medical Research

Calendar

04-22 - Q4 2025 Earnings Release (Projected)

More about the company